Minimization of cisplatin nephrotoxicity in high-risk patients.
Donadio
C
C
Lucchesi
A
A
Gadducci
A
A
D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000473:pathology / Q000517:prevention & control; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002945:Cisplatin / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007677:Kidney Function Tests; D008875:Middle Aged; D009375:Neoplasms, Glandular and Epithelial / Q000150:complications / Q000188:drug therapy; D010051:Ovarian Neoplasms / Q000150:complications / Q000188:drug therapy; D012306:Risk
D000970:Antineoplastic Agents; D002945:Cisplatin